Lista de obras - Gerty Schreibelt - Dominio Público Uruguay

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

artículo científico

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

artículo científico publicado en 2016

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients

artículo científico publicado en 2015

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

artículo científico publicado en 2016

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

scientific article published on 24 January 2020

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

artículo científico publicado en 2018

Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study

artículo científico publicado en 2003

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

artículo científico publicado en 2019

CD1 and major histocompatibility complex II molecules follow a different course during dendritic cell maturation

artículo científico publicado en 2003

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells

artículo científico publicado en 2010

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

artículo científico

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

artículo científico publicado en 2018

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

artículo científico publicado en 2016

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

artículo científico publicado en 2016

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance

artículo científico publicado en 2018

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy

artículo científico

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

article

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cells

artículo científico publicado en 2015

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

artículo científico publicado en 2016

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

artículo científico publicado en 2015

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

article

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

artículo científico publicado en 2020

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination

artículo científico publicado en 2020

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

artículo científico publicado en 2012

Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.

artículo científico publicado en 2018

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.

artículo científico publicado en 2016

Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome

artículo científico publicado en 2017

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy.

artículo científico publicado en 2013

In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients

artículo científico publicado en 2009

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

artículo científico publicado en 2015

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

artículo científico publicado en 2016

Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity

artículo científico publicado en 2006

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients

artículo científico publicado en 2014

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.

artículo científico publicado en 2008

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

artículo científico publicado en 2017

NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions

artículo científico publicado en 2006

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

article

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells

artículo científico publicado en 2018

Opportunities for immunotherapy in microsatellite instable colorectal cancer

artículo científico publicado en 2016

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

artículo científico publicado en 2015

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

artículo científico

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

artículo científico publicado en 2011

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.

artículo científico publicado en 2008

Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation

artículo científico publicado en 2015

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

artículo científico publicado en 2016

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

artículo científico publicado en 2015

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier

artículo científico publicado en 2008

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

artículo científico publicado en 2016

Radical changes in multiple sclerosis pathogenesis

artículo científico publicado en 2010

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

artículo científico publicado en 2007

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

artículo científico publicado en 2015

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination

artículo científico publicado en 2013

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

artículo científico publicado en 2011

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression

artículo científico publicado en 2008

Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma

artículo científico publicado en 2012

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination

artículo científico publicado en 2012

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

artículo científico publicado en 2013

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

scientific article published on 04 February 2013

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

scientific article published on 10 January 2012

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

artículo científico publicado en 2019

Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology

artículo científico publicado en 2007

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

artículo científico publicado en 2010

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

article

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

artículo científico publicado en 2020

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

article

Lista de obras de Gerty Schreibelt

A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets.

Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma.

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients

Adjuvant dendritic cell vaccination induces tumor-specific immune responses in the majority of stage III melanoma patients.

Autologous monocyte-derived DC vaccination combined with cisplatin in stage III and IV melanoma patients: a prospective, randomized phase 2 trial

BDCA1+CD14+ Immunosuppressive Cells in Cancer, a Potential Target?

Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study

Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

CD1 and major histocompatibility complex II molecules follow a different course during dendritic cell maturation

Commonly used prophylactic vaccines as an alternative for synthetically produced TLR ligands to mature monocyte-derived dendritic cells

Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy

Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time

Dendritic Cell-Based Immunotherapy: State of the Art and Beyond.

Dendritic cell vaccination in melanoma patients: From promising results to future perspectives

Development of an RNA-based kit for easy generation of TCR-engineered lymphocytes to control T-cell assay performance

Early predictive value of multifunctional skin-infiltrating lymphocytes in anticancer immunotherapy

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Enterovirus-infected β-cells induce distinct response patterns in BDCA1+ and BDCA3+ human dendritic cells

Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

Favorable overall survival in stage III melanoma patients after adjuvant dendritic cell vaccination.

Health-related quality of life analysis in stage III melanoma patients treated with adjuvant dendritic cell therapy

High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

Human pDCs Are Superior to cDC2s in Attracting Cytolytic Lymphocytes in Melanoma Patients Receiving DC Vaccination

Human plasmacytoid dendritic cells efficiently cross-present exogenous Ags to CD8+ T cells despite lower Ag uptake than myeloid dendritic cell subsets.

Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.

Immune-related Adverse Events of Dendritic Cell Vaccination Correlate With Immunologic and Clinical Outcome in Stage III and IV Melanoma Patients.

Immunotherapy holds the key to cancer treatment and prevention in constitutional mismatch repair deficiency (CMMRD) syndrome

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy.

In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination

Lipoic acid affects cellular migration into the central nervous system and stabilizes blood-brain barrier integrity

Long Overall Survival After Dendritic Cell Vaccination in Metastatic Uveal Melanoma Patients

Maturation of monocyte-derived dendritic cells with Toll-like receptor 3 and 7/8 ligands combined with prostaglandin E2 results in high interleukin-12 production and cell migration.

Monitoring of dynamic changes in Keyhole Limpet Hemocyanin (KLH)-specific B cells in KLH-vaccinated cancer patients.

NAD(P)H:quinone oxidoreductase 1 expression in multiple sclerosis lesions

Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells

Opportunities for immunotherapy in microsatellite instable colorectal cancer

PLGA-encapsulated perfluorocarbon nanoparticles for simultaneous visualization of distinct cell populations by 19F MRI.

PTEN Hamartoma Tumor Syndrome and Immune Dysregulation

Paradigm Shift in Dendritic Cell-Based Immunotherapy: From in vitro Generated Monocyte-Derived DCs to Naturally Circulating DC Subsets.

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

Polyinosinic polycytidylic acid prevents efficient antigen expression after mRNA electroporation of clinical grade dendritic cells.

Primary Human Blood Dendritic Cells for Cancer Immunotherapy-Tailoring the Immune Response by Dendritic Cell Maturation

Prophylactic vaccines are potent activators of monocyte-derived dendritic cells and drive effective anti-tumor responses in melanoma patients at the cost of toxicity.

Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets

Protective effects of peroxiredoxin-1 at the injured blood-brain barrier

Proteomics of Human Dendritic Cell Subsets Reveals Subset-Specific Surface Markers and Differential Inflammasome Function

Radical changes in multiple sclerosis pathogenesis

Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling

Recurrent candidiasis and early-onset gastric cancer in a patient with a genetically defined partial MYD88 defect

Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination

Route of Administration Modulates the Induction of Dendritic Cell Vaccine-Induced Antigen-Specific T Cells in Advanced Melanoma Patients

Severe oxidative damage in multiple sclerosis lesions coincides with enhanced antioxidant enzyme expression

Skin-Test Infiltrating Lymphocytes Early Predict Clinical Outcome of Dendritic Cell-Based Vaccination in Metastatic Melanoma

Targeting CD4(+) T-helper cells improves the induction of antitumor responses in dendritic cell-based vaccination

Targeting Uptake Receptors on Human Plasmacytoid Dendritic Cells Triggers Antigen Cross-Presentation and Robust Type I IFN Secretion

Targeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells

The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells

The clinical application of cancer immunotherapy based on naturally circulating dendritic cells

Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology

Toll-like receptor expression and function in human dendritic cell subsets: implications for dendritic cell-based anti-cancer immunotherapy

Vaccination with mRNA-Electroporated Dendritic Cells Induces Robust Tumor Antigen-Specific CD4+ and CD8+ T Cells Responses in Stage III and IV Melanoma Patients

What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used